News about Biotechnology

Layered Nanoparticle Platform Could Expand Targeted Radioisotope Cancer Therapies

Scientists have developed a specialised nanoplatelet that rapidly captures and strongly retains radioisotopes, potentially creating a versatile platform for targeted cancer imaging, radionuclide therapy and theranostic applications.

Biotechnology | 19/08/2026 | By News Bureau |  141

SOPHiA GENETICS and AstraZeneca Partner to Develop Two Companion Diagnostics for Precision Oncology

SOPHiA GENETICS and AstraZeneca have launched a multi-year collaboration to develop two companion diagnostics for solid tumours and blood cancers, supporting broader access to precision oncology therapies.

Biotechnology | 18/08/2026 | By News Bureau |  137

Sobi and Innate Pharma Partner to Advance Lacutamab in T-Cell Lymphoma

Sobi and Innate Pharma partners to advance lacutamab into the TELLOMAK-3 Phase 3 trial, supporting its potential accelerated approval in Sézary syndrome and future development across cutaneous T-cell lymphoma.

Biotechnology | 10/08/2026 | By News Bureau |  143

India Expands AI-Driven Biotechnology Research across Genomics, Healthcare and Biomanufacturing

The Government of India is advancing AI-driven biotechnology through GenomeIndia, Bio-AI Hubs, IBDC and medical imaging initiatives to boost precision medicine and healthcare.

Biotechnology | 31/07/2026 | By News Bureau |  240

Dr. Jitendra Singh Unveils Phase 3 of Biomedical Research Career Program

Dr. Jitendra Singh launched phase 3 of the Biomedical Research Career Programme (BRCP), backed by DBT and Wellcome Trust, to strengthen India's biomedical workforce and support a USD 300 billion bioeconomy by 2030.

Biotechnology | 16/07/2026 | By News Bureau |  146

Innovent Biologics Licenses Anti-CD40L Therapy IBI355 to Spero Therapeutics in USD 1.1 Billion Deal

Innovent Biologics has licensed global rights outside Greater China for its anti-CD40L antibody IBI355 to Spero Therapeutics in a deal valued at up to USD 1.1 billion, advancing the development of a potential new treatment for autoimmune diseases including IgG4-related disease and Sjögren's disease.

Biotechnology | 15/07/2026 | By News Bureau |  262

Formycon and OneSource Partner to Manufacture Biosimilars

Formycon and OneSource Specialty Pharma have partnered to manufacture biosimilars, with OneSource providing integrated Drug Substance (DS) and Drug Product (DP) manufacturing from its Bengaluru biologics facility.

Biotechnology | 15/07/2026 | By News Bureau |  152

Parexel Launches Biotech Incubator for Early-stage Innovators

Parexel has launched the Parexel Biotech Incubator to support early-stage therapeutics companies with clinical development expertise and strategic resources. The initiative includes a founding partnership with Cape Fear BioCapital to connect incubator to a seed-stage venture partner.

Biotechnology | 24/06/2026 | By News Bureau |  244

India Poised to Become a Global Biopharma Leader: Anupriya Patel

Union Minister Anupriya Patel said India is well-positioned to become a global biopharma leader, highlighting the Biopharma SHAKTI initiative’s goal of launching 100 biologics by 2047. She urged the industry to strengthen capabilities in biologics and biosimilars.

Biotechnology | 12/06/2026 | By News Bureau |  222

Roche and Nurix Partner to Develop BTK Degrader Bexobrutideg

Roche and Nurix Therapeutics have partnered to develop and commercialise bexobrutideg, a potential best-in-class BTK degrader for B-cell malignancies, chronic spontaneous urticaria, and Multiple Sclerosis (MS), aiming to overcome resistance to current BTK inhibitors.

Biotechnology | 09/06/2026 | By News Bureau |  195